RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xiangxue Pharmaceutical Co Stock

Xiangxue Pharmaceutical Co ROE 2024

Xiangxue Pharmaceutical Co ROE

-0.2

Ticker

300147.SZ

ISIN

CNE100000Y92

In 2024, Xiangxue Pharmaceutical Co's return on equity (ROE) was -0.2, a -12.56% increase from the -0.23 ROE in the previous year.

Xiangxue Pharmaceutical Co Aktienanalyse

What does Xiangxue Pharmaceutical Co do?

Xiangxue Pharmaceutical Co Ltd is one of the leading companies in the field of traditional Chinese medicine. The company was founded in 1994 and has since undergone impressive development. Originally started as a small company, Xiangxue now has a market share of 10% and is listed on the stock exchange. The company's business model is based on the manufacturing and sale of traditional Chinese medicines. Various herbs and plants are processed into powders, tablets, or liquids and offered in the form of medicines. The application of the products follows the principles of Chinese medicine, which aim to restore the balance between yin and yang in the body. Xiangxue is divided into different divisions to meet the various needs of customers. The largest division is basic care, which focuses on general health care and offers products such as dietary supplements, enzyme preparations, and vitamins. The second division deals with the treatment of digestive system disorders. Here, Xiangxue offers a wide range of products, ranging from the prevention of gastrointestinal complaints to the treatment of conditions such as gastritis and colitis. The third division covers the treatment of respiratory system disorders such as asthma and chronic bronchitis. The company also offers a variety of products in this area, allowing for a broad range of applications. Additionally, there is a division that specializes in the treatment of colds and flu. One of Xiangxue's most famous products is "Shexiang Zhuifeng Gao," a pain-relieving patch. The product has been popular in China and other Asian countries for many years and has also gained international recognition. It is an effective pain relief product that can be used in the treatment of joint pain, back pain, and other pain conditions. In addition to its medicines, Xiangxue also conducts research and development to improve its production processes and active ingredients. The company has a strong research department that focuses on Chinese medicine and collaborates closely with academic institutions and research facilities. Overall, Xiangxue has a strong focus on quality and innovation. The company strives to provide its customers with high-quality products based on traditional Chinese healing methods while also delivering scientific performance. The company is able to meet the high standards of the pharmaceutical industry while maintaining its deep roots in Chinese medicine. Xiangxue understands the needs of its customers and has developed a successful strategy to provide them with the best possible healthcare. The company is an important player in the industry and has earned the respect and loyalty of its customers. Xiangxue Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Xiangxue Pharmaceutical Co's Return on Equity (ROE)

Xiangxue Pharmaceutical Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Xiangxue Pharmaceutical Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Xiangxue Pharmaceutical Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Xiangxue Pharmaceutical Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Xiangxue Pharmaceutical Co stock

What is the ROE (Return on Equity) of Xiangxue Pharmaceutical Co this year?

The ROE of Xiangxue Pharmaceutical Co this year is -0.2 undefined.

How has the Return on Equity (ROE) of Xiangxue Pharmaceutical Co developed compared to the previous year?

The ROE of Xiangxue Pharmaceutical Co has increased by -12.56% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Xiangxue Pharmaceutical Co?

A high ROE indicates that Xiangxue Pharmaceutical Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Xiangxue Pharmaceutical Co?

A low ROE can indicate that Xiangxue Pharmaceutical Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Xiangxue Pharmaceutical Co affect the company?

A change in ROE (Return on Equity) of Xiangxue Pharmaceutical Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Xiangxue Pharmaceutical Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Xiangxue Pharmaceutical Co?

Some factors that can influence Xiangxue Pharmaceutical Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Xiangxue Pharmaceutical Co pay?

Over the past 12 months, Xiangxue Pharmaceutical Co paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 0.7 %. For the coming 12 months, Xiangxue Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Xiangxue Pharmaceutical Co?

The current dividend yield of Xiangxue Pharmaceutical Co is 0.7 %.

When does Xiangxue Pharmaceutical Co pay dividends?

Xiangxue Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, September, July.

How secure is the dividend of Xiangxue Pharmaceutical Co?

Xiangxue Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Xiangxue Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xiangxue Pharmaceutical Co located?

Xiangxue Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xiangxue Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xiangxue Pharmaceutical Co from 6/23/2020 amounting to 0.046 CNY, you needed to have the stock in your portfolio before the ex-date on 6/23/2020.

When did Xiangxue Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/23/2020.

What was the dividend of Xiangxue Pharmaceutical Co in the year 2023?

In the year 2023, Xiangxue Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Xiangxue Pharmaceutical Co pay out the dividend?

The dividends of Xiangxue Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xiangxue Pharmaceutical Co

Our stock analysis for Xiangxue Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xiangxue Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.